CHK1 is overexpressed in multiple cancer types such as gastric cancer [155], lung adenocarcinoma [156], hepatocellular carcinoma [157], colorectal cancer [158], T-cell acute lymphoblastic leukemia [159], triple-negative breast cancer [160], and nasopharyngeal carcinoma [161]. Here, CHEK1 is linked to cancer.